Elion Raises $9.3M for Healthcare AI Research and Intelligence Platform

NEW YORK--(BUSINESS WIRE)--Elion, the AI-powered research and intelligence platform for healthcare technology, today announced the close of an oversubscribed $9.3 million seed round. The financing was led by existing Elion investor, NEA, with participation from new investors Cedars Sinai Health Ventures, TMV, Scrub Capital, and Alumni Ventures.

“We’re reimagining what a technology research and advisory business looks like in the age of generative AI,” said Bobby Guelich, Elion’s CEO and cofounder.

Share

As generative AI and other advanced technologies transform healthcare, provider organizations are under growing pressure to make faster, smarter technology decisions. Yet most lack the structured intelligence, internal expertise, or dedicated resources needed to confidently evaluate an increasingly complex vendor landscape.

Elion is building the trusted platform healthcare leaders rely on for clear, credible insights into emerging technologies and the companies behind them. By combining a structured dataset of thousands of healthcare vendors with deep expertise in the workflows and decision-making dynamics of health systems, Elion delivers fast, high-quality guidance to help provider organizations evaluate solutions with confidence and clarity.

“We’re reimagining what a technology research and advisory business looks like in the age of generative AI,” said Bobby Guelich, Elion’s CEO and cofounder. “The starting point is our vendor marketplace, which has quickly become the go-to resource for health systems and provider organizations trying to make sense of a crowded and fast-changing landscape. The depth of our vendor and product intelligence, combined with our ability to deliver it in a structured, accessible format, is helping healthcare leaders make better, faster decisions.”

Elion has seen strong traction, with over 60% of U.S. health systems utilizing its vendor marketplace and a 5x increase in usage over the past year. This engagement reflects growing trust in Elion as a credible resource for health system decision-makers in an increasingly high-stakes technology environment.

“Elion gives me a clear, structured view of the health tech landscape—without the noise. It helps me quickly identify the right partners to advance our digital and innovation goals,” said Tom Maddox, MD SM, Vice President of Digital Products & Innovation at BJC.

Investor enthusiasm has followed Elion’s momentum. “Cedars Sinai Health Ventures is excited to partner with Elion as they empower healthcare leaders with the insights they need to navigate an increasingly complex vendor landscape,” said Maureen Burgess, Partner at Cedars Sinai Health Ventures. “We believe Elion is poised to become a valuable tool for healthtech intelligence—helping hospitals, investors, and innovators make smarter, data-driven choices.”

Joining Cedars Sinai Health Ventures in the round are TMV, Alumni Ventures, and Scrub Capital, a new fund founded by veteran healthcare investors Chrissy Farr, Dr. Rebecca Mitchell, and Dr. Jon Slotkin. Elion also saw strong participation from existing investors, including lead investor NEA, Max Ventures, AlleyCorp, and Floating Point, reflecting continued confidence in its vision and momentum.

“GenAI created a surge of health tech solutions,” said Michael Li, Principal at NEA. “But adoption has lagged as providers face an overwhelming array of high-stakes choices and time-consuming research. Elion accelerates tech adoption and time-to-value so providers can focus on taking care of patients, not applications. We're thrilled to continue partnering with Bobby and the Elion team as they build the go-to platform for healthcare technology decision-makers.”

The new capital will accelerate platform development, support the launch of new products, and scale Elion’s reach across the healthcare technology ecosystem. To power this next phase of growth, the company is expanding its team across engineering, research, and marketing. With this momentum, Elion is advancing its mission to become the trusted intelligence platform for technology decisions across the healthcare industry.

About Elion:
Elion is a trusted health IT marketplace and research firm dedicated to empowering healthcare organizations through technology insights and strategic guidance. By bridging the gap between healthcare leaders and innovative solutions, Elion is driving the future of healthcare delivery.

For more information, visit: https://elion.health